News

Published on 22 Mar 2024 on Zacks via Yahoo Finance

InflaRx N.V. (IFRX) Reports Q4 Loss, Misses Revenue Estimates


Article preview image

InflaRx N.V. (IFRX) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.18 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -50%. A quarter ago, it was expected that this company would post a loss of $0.29 per share when it actually produced a loss of $0.14, delivering a surprise of 51.72%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

NASDAQ.IFRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
InflaRx N.V. (IFRX) Reports Q4 Loss, Misses Revenue Estimates

InflaRx N.V. (IFRX) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus ...

Zacks via Yahoo Finance 22 Mar 2024

InflaRx N.V.'s (NASDAQ:IFRX) top owners are individual investors with 55% stake, while 23% is held...

Key Insights Significant control over InflaRx by individual investors implies that the general pu...

Simply Wall St. via Yahoo Finance 22 Jan 2024

After Plunging -17.65% in 4 Weeks, Here's Why the Trend Might Reverse for InflaRx N.V. (IFRX)

InflaRx N.V. (IFRX) has been beaten down lately with too much selling pressure. While the stock h...

Zacks via Yahoo Finance 28 Nov 2023

Here's Why InflaRx N.V. (IFRX) Looks Ripe for Bottom Fishing

InflaRx N.V. (IFRX) witnesses a hammer chart pattern, indicating support found by the stock after...

Zacks · via Yahoo Finance 17 Nov 2023

InflaRx N.V. (IFRX) Loses -47.13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

InflaRx N.V. (IFRX) has been beaten down lately with too much selling pressure. While the stock h...

Zacks via Yahoo Finance 7 Nov 2023

12 Best German Stocks To Buy Now

In this piece, we will take a look at the 12 best German stocks to buy now. If you want to skip o...

Insider Monkey via Yahoo Finance 31 Oct 2023

Biotech Stock Roundup: FGEN Down on Study Failure, BMY Drug's Label Expansion & More

It was a busy week for the biotech sector, with quite a few important regulatory and pipeline upd...

Zacks via Yahoo Finance 31 Aug 2023

InflaRx (IFRX) Skyrockets 110% in Six Months: Here's Why

In the past six months, InflaRx’s IFRX shares have surged 110.1% against the industry’s 7.2% fall...

Zacks via Yahoo Finance 21 Aug 2023

Retail investors who have a significant stake must be disappointed along with institutions after...

Key Insights InflaRx's significant retail investors ownership suggests that the key decisions are...

Simply Wall St. via Yahoo Finance 21 Aug 2023

InflaRx N.V.'s (NASDAQ:IFRX) Profit Outlook

InflaRx N.V. (NASDAQ:IFRX) is possibly approaching a major achievement in its business, so we wou...

Simply Wall St. via Yahoo Finance 19 Apr 2023